Page 327 - FINAL PROGRAMME 2017

P-792 Procoagulant properties of circulating microparticles, and subsequent intravascular coagulation, in women with ovarian hyper stimulation for in vitro fertilization
S. Cointe1, E. Dos Santos2, R. Lacroix3, F. Vialard2, J. Selva Rameix4, S. Valérie2, D.G. Françoise5, R. Wainer6, A. Fauconnier7, F. Boitrelle8, S. Florence9, A. Torre10
1Faculté de Pharmacie de Marseille-, VRCM- UMR-S1076, Marseille, France
2Université de Versailles Saint Quentin en Yvelines, EA7404- Gamètes- implantation- gestation, Saint Quentin en Yvelines, France
3Faculté de Pharmacie de Marseille, INSERM UMR-S 608, Marseille, France
4Centre Hospitalier Poissy - St. Germain, Biologie de la Reproduction, Poissy, France
5Faculté de Pharmacie de Marseille, VRCM- UMR-S1076, Marseille, France
6Hôpital de Poissy Saint Germain en Laye, Service de Gynécologie Obstétrique-, Poissy, France
7EA7285- Risques cliniques et sécurité en santé des femmes et en santé périnatale, Université de Versailles Saint Quentin en Yvelines, Saint Quentin en Yvelines, France
8EA7404- Gamètes- implantation- gestation-, Université de Versailles Saint Quentin en Yvelines, Saint Quentin en Yvelines, France
9Faculté de Pharmacie de Marseille, VRCM- UMR-S1076, Marseille, France
10Arnaud de Villeneuve Univertity hospital of Montpellier, Department of Reproductive Medicine, Montpellier, France
P-793 Effects of FSH vs LH stimulation on bone metabolism
M. Schmidmayr1, A. RItzinger2, B. Lesoine3, D. Berg4, V. Seifert-Klauss5
1Technische Universität München, Frauenklinik und Poliklinik- Klinikum rechts der Isar, München, Germany
2Technische Universität München, Frauenklinik und Poliklinik - Klinikum rechts der Isar, Munich, Germany
3A.R.T. Bogenhausen GmBH, A.R.T Bogenhausen GmbH, Munich, Germany 4A.R.T. Bogenhausen GmbH, A.R.T. Bogenhausen GmbH, Munich, Germany
5Technische Universität München, Frauenklinik und Poliklinik- Klinikum rechts der Isar, Munich, Germany
P-794 Morbidity and mortality associated with assisted reproduction tecniques (ART) in our hospital since 2011 to 2016
M. Urtasun Murillo1, S. García-Francés1, J. Barrenetxea Arrinda1, B. Pérez Munárriz1,
N. Abian Franco1, A. Safont Gascon2, B. Gastón Moreno1, I. Zabaleta Loinaz1, M. Ruiz García1, J. Zabaleta Jurio1, M. Huarte Ciganda1, G. Campo Molina1
1Complejo Hospitalario de Navarra, Obstetricia y Ginecología, Pamplona, Spain 2Complejo Hospitalario de Navarra, Ostetricia y ginecología, Pamplona, Spain
P-795 Triplet-to-twin fetal reduction may increase risk of demise in the remaining fetuses
S. Santos Ribeiro1,2, H. Tournaye1, N.P. Polyzos1,3,4
1Universitair Ziekenhuis Brussel, Centre for Reproductive Medicine, Brussels, Belgium
2Santa Maria University Hospital, Department of Obstetrics- Gynaecology and Reproductive Medicine, Lisbon, Portugal
3Dexeus University Hospital, Department of Reproductive Medicine, Barcelona, Spain 4Faculty of Health University of Aarhus, Department of Clinical Medicine, Aarhus, Denmark
FINAL PROGRAMME I GENEVA, SWITZERLAND – 2 TO 5 JULY 2017 327
POSTERS